No Data
No Data
Analysis of the Zhitong Hong Kong Stock Connect Holdings | April 4th
Analysis of holdings through Hong Kong Stock Connect | April 3, 2025
Analysis of Zhitong Hong Kong Stock Connect Holdings | April 3rd
Analysis of Hong Kong Stock Connect Holdings | April 2, 2025
BAIYUNSHAN PH (00874.HK): Hepatitis B detox capsules and others have received approval for supplementary applications.
On March 28, Gelonghui reported that BAIYUNSHAN PH (00874.HK) announced that its subsidiary, Guangzhou BAIYUNSHAN PH Pharmaceutical Group Co., Ltd., BAIYUNSHAN Pharmaceutical General Factory (hereinafter referred to as "BAIYUNSHAN Pharmaceutical General Factory"), received the "Pharmaceutical Supplementary Application Approval Notice" issued by the National Medical Products Administration. The BAIYUNSHAN Pharmaceutical General Factory has obtained the "Pharmaceutical Supplementary Application Approval Notice" for Hepatitis B detoxification capsules and Rhododendron capsules, improving the safety information and other details of the aforementioned pharmaceuticals. This helps ensure the safe, effective, and rational use of these medications, which is beneficial for enhancing the market competitiveness of the product. This approval of the "Pharmaceutical Supplementary Application Approval Notice" is significant.
BAIYUNSHAN PH (600332.SH): Injection of sodium ampicillin has passed the consistency evaluation for generic drugs.
On March 28, Gelonghui reported that BAIYUNSHAN PH (600332.SH) announced that its holding subsidiary, Guangzhou BAIYUNSHAN PH Tianxin Pharmaceutical Co., Ltd., received the "Pharmaceutical Supplement Application Approval Notice" issued by the National Medical Products Administration, indicating that the injectable Ampicillin Sodium (1.0g, 0.5g) has passed the consistency evaluation of quality and efficacy for generic drugs. Injectable Ampicillin Sodium is a broad-spectrum semi-synthetic penicillin used for respiratory infections, gastrointestinal infections, urinary tract infections, soft tissue infections, endocarditis, meningitis, sepsis, and other infections caused by sensitive bacteria.
Express News | BAIYUNSHAN PH: The branch company has obtained the approval for the additional Pharmaceutical application.
Express News | BAIYUNSHAN PH: The subsidiary's Pharmaceutical has passed the consistency evaluation for generic drugs.